酮内酯类药物ABT-773和泰利霉素以及三种大环内酯类药物对肺炎链球菌、化脓性链球菌、流感嗜血杆菌和卡他莫拉菌基因特征明确的分离株的体外活性。 - Suppr

Suppr

超能文献

In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.

作者信息

Schmitz F-J, Schwarz S, Milatovic D, Verhoef J, Fluit A C

出版信息

J Antimicrob Chemother. 2002 Jul;50(1):145-8. doi: 10.1093/jac/dkf085.

DOI:10.1093/jac/dkf085

PMID:12096026

Abstract

摘要

相似文献

In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.

J Antimicrob Chemother. 2002 Jul;50(1):145-8. doi: 10.1093/jac/dkf085.

In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.

Int J Antimicrob Agents. 2003 Nov;22(5):497-501. doi: 10.1016/s0924-8579(03)00150-x.

Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.

J Antimicrob Chemother. 2004 May;53(5):793-6. doi: 10.1093/jac/dkh178. Epub 2004 Mar 31.

Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.

J Antimicrob Chemother. 2004 Aug;54(2):542-5. doi: 10.1093/jac/dkh339. Epub 2004 Jun 23.

Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.

J Infect. 2002 Feb;44 Suppl A:3-10.

In vitro activity of the new ketolide ABT-773 against community acquired respiratory tract isolates and Viridans Streptococci.

Diagn Microbiol Infect Dis. 2002 Feb;42(2):107-12. doi: 10.1016/s0732-8893(01)00323-6.

Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000).

Chemotherapy. 2004 Jun;50(3):143-51. doi: 10.1159/000077889.

In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Diagn Microbiol Infect Dis. 1999 Sep;35(1):37-44. doi: 10.1016/s0732-8893(99)00053-x.

Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).

Braz J Infect Dis. 2003 Feb;7(1):44-61. doi: 10.1590/s1413-86702003000100006.

Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studies.

Clin Microbiol Infect. 2004 Jan;10(1):27-36. doi: 10.1111/j.1469-0691.2004.00752.x.

引用本文的文献

Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms.

Microorganisms. 2020 Jan 30;8(2):191. doi: 10.3390/microorganisms8020191.

Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective.

Clin Pharmacokinet. 2009;48(1):23-38. doi: 10.2165/0003088-200948010-00002.

In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.

Folia Microbiol (Praha). 2007;52(6):593-9. doi: 10.1007/BF02932188.

Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.

Antimicrob Agents Chemother. 2006 Sep;50(9):3033-8. doi: 10.1128/AAC.00920-05.

In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.

Antimicrob Agents Chemother. 2005 Jun;49(6):2487-9. doi: 10.1128/AAC.49.6.2487-2489.2005.

Telithromycin.

Drugs. 2004;64(15):1683-94; discussion 1695-6. doi: 10.2165/00003495-200464150-00006.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验